Two MLSC portfolio companies are featured in BostInno’s 2020 Inno on Fire honorees:
Nutrimedy: Brookline-based Nutrimedy is a telehealth app and online platform that connects patients with registered dieticians. These dieticians can offer guidance on over 50 conditions, regardless of physical location.
In 2020, Nutrimedy became a Seed Fund recipient. The MLSC program targets pre-seed to early-stage life sciences companies, in specific geographic locations, who have not yet raised their first priced round. The program will invest up to $250,000 in a convertible note.
Olaris: This biopharma startup ended 2019 with $4.2 million in Series A financing and is on the verge of commercialization. Led by CEO and founder Dr. Elizabeth O’Day, Olaris has created a “Biomarkers of Response” platform to determine whether a patient will respond to certain drugs or treatments for certain types of diseases.
Olaris was a Massachusetts Next Generation Initiative (MassNextGen) awardee during the program’s inaugural year in 2018. MassNextGen is a competitive program to support women entrepreneurs in early-stage life sciences companies. Through MassNextGen, the MLSC has deployed more than $1 million in funding for women entrepreneurs with an executive coaching network providing 200-plus hours of coaching.